Systemic lupus international collaborating clinics renal activity/response exercise: Comparison of agreement in rating renal response

Arthritis and Rheumatism

Volumn 58, Issue 6, 2008, Pages 1789-1795

  Petri, Michelle ^a   Kasitanon, Nuntana ^a   Singh, Sukminder ^a   Link, Kimberly ^a   Magder, Laurence ^b   Bae, Sang Cheol ^c   Hanly, John G ^d   Nived, Ola ^e   Sturfelt, Gunnar ^e   Van Vollenhoven, Ronald ^f   Wallace, Daniel J ^g   Alarcón, Graciela S ^h   Adu, Dwomoa ⁱ   Avila Casado, Carmen ^j   Bernatsky, Sasha R ^k   Bruce, Ian N ^l   Clarke, Ann E ^k   Contreras, Gabriel ^m   Fine, Derek M ^a   Gladman, Dafna D ⁿ   Gordon, Caroline ^o   Kalunian, Kenneth C ^p   Madaio, Michael P ^q   Rovin, Brad H ^r   Sanchez Guerrero, Jorge ^s   Steinsson, Kristjan ^t   Aranow, Cynthia ^u   Balow, James E ^v   Buyon, Jill P ^w   Ginzler, Ellen M ^x   Khamashta, Munther A ^y   Urowitz, Murray B ⁿ   Dooley, Mary Anne ^z   Merrill, Joan T ^aa   Ramsey Goldman, Rosalind ^ab   Font, Josef ^af   Tumlin, James ^ac   Stoll, Thomas ^ad   Zoma, Asad ^ae   more..

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^c Hanyang University Medical Center   (South Korea)

^d QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁱ QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^j INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^k MONTREAL GENERAL HOSPITAL   (Canada)

^l MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^m UNIVERSITY OF MIAMI   (United States)

ⁿ UNIVERSITY OF TORONTO   (Canada)

^o UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^r THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^s Instituto National de la Nutricion   (Mexico)

^t LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^u NewYork Presbyterian Hospital   (United States)

^v NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^w NYU HOSPITAL FOR JOINT DISEASES   (United States)

^x SUNY DOWNSTATE MEDICAL CENTER   (United States)

^y ST THOMAS HOSPITAL   (United Kingdom)

^z UNIVERSITY OF NORTH CAROLINA   (United States)

^aa OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^ab NORTHWESTERN UNIVERSITY   (United States)

^ac UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^ad KANTONSSPITAL   (Switzerland)

^ae HAIRMYRES HOSPITAL   (United Kingdom)

^af NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYCHLOROQUINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; RITUXIMAB;

ARTICLE; CALCULATION; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CORRELATION COEFFICIENT; HUMAN; KAPPA STATISTICS; KIDNEY FUNCTION; KIDNEY RESPONSE INDEX; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MEDICAL RECORD; NEPHROLOGIST; PHYSICIAN; PRIORITY JOURNAL; RATING SCALE; RHEUMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE;

HUMANS; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; NEPHROLOGY; OBSERVER VARIATION; RHEUMATOLOGY; SEVERITY OF ILLNESS INDEX;

EID: 45349106761     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23802     Document Type: Article

References (18)

1. Petri M, Barr SG, Buyon J, Davis J, Ginzler E, Kalunian K, et al. RIFLE: Responder Index for Lupus Erythematosus [abstract]. Arthritis Rheum 2000;43 Suppl 9:S244.
2. Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. QJM 1993;86:447-58.
3. Cross J, Dwomoa A, Andrews P, Burns A, Gordon C, Main J, et al, on behalf of the Renal Association Clinical Trials Subcommittee. Mycophenolate mofetil for remission induction in severe lupus nephritis. Nephron Clin Pract 2005;100:c92-100.
4. Kasitanon N, Fine DM, Haas M, Magder LS, Petri M. Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis. Lupus 2006;15:366-70.
5. Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 2005;353:2219-28.
6. Burt RK, Traynor A, Statkute L, Barr WG, Rosa R, Schroeder J, et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. J Amer Med Assoc 2006;295: 527-35.
7. Stoll T, Stucki G, Malik J, Pyke S, Isenberg DA. Further validation of the BILAG disease activity index in patients with systemic lupus erythematosus. Ann Rheum Dis 1996;55:756-60.
8. Isenberg DA, Rahman A, Allen E, Farewell V, Akil M, Bruce IN, et al. BILAG 2004: development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford) 2005;44:902-6.
9. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
10. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict GFR from S-creatinine [abstract]. J Am Soc Nephrol 2000;11:155A.
11. Churg J, Sobin LH. Classification of glomerular disease. In: Churg J, Sobin LH, editors. Renal disease classification and atlas of glomerular diseases. Tokyo: Igaku Shoin; 1982. p. 3-19.
12. Churg J, Bernstein J, Glassock RJ. Classification of glomerular disease. In: Churg J, Bernstein J, Glassock RH, editors. Renal disease classification and atlas of glomerular diseases. 2nd ed. Tokyo: Igaku Shoin; 1995. p. 151-6.
13. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, AIpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15:241-50.
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, for the Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130: 461-70.
15. Altman DG. Some common problems in medical research. In: Practical statistics for medical research. Altman DG, editor. Washington (DC): Chapman & Hall/CRC; 1999. p. 396-439.
16. Tumlin JA, Hennigar RA. Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy. Semin Nephrol 2004;24:256-68.
17. Gunnarsson I, Sundelin B, Heimburger M, Forslid J, van Vollenhoven R, Lundberg I, et al. Repeated renal biopsy in proliferative lupus nephritis: predictive role of serum CIq and albuminuria. J Rheumatol 2002;29:693-9.
18. Tsokos G, Gordon C, Smolen J, editors. A companion to Rheumatology: Systemic lupus erythematosus. Philadelphia: Mosby Elsevier; 2007. Appendix H: BILAG 2004 scoring. p. 542-5.